SecBot SecBot

DYAI

DYADIC INTERNATIONAL INC
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001213809 Biotech & Drug Discovery
$0.3953 −0.02 (−5.88%)
Oct 27 4:00 PM ET · prev $0.4200
Market cap
$16.0M
Nano cap
Median target
$5.50
+1291% · range $4.00–7.00
Next earnings
Nov 11
in 15 days · EPS est. −$0.04
1 year
−66.5%
from $1.18 · Oct 27
30 days
−15.9%
from $0.4700
52-week range
$0.3800–1.47
−73% from high · low Oct 19
Avg volume 20D
104.5K
Oct 15 spike 508.8K
Short interest
🔒 Subscribers only
Insider net
−$125.0K
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 5 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/6 ·Next Earnings date, Nov 11, 2026
Strongest BEARISH Dyadic International received two Nasdaq deficiency notices on September 25, 2026: one for failing to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $125.0K.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 1 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.040 → −$0.040 over 90 days.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM197,749$177.2K
NORTHERN TRUST CORPDOUBLED69,745$62.5K
WELLS FARGO & COMPANY/MNDOUBLED878$787.00
BARCLAYS PLCDOUBLED159$143.00
RENAISSANCE TECHNOLOGIES LLCTRIM81,665$67.0K
LPL Financial LLCTRIM33,038$27.1K
NORTHERN TRUST CORPTRIM32,851$26.9K
COMMONWEALTH EQUITY SERVICES, LLCTRIM12,579$10.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Nov 2024
12-month targets · 2 analysts

Price is below the lowest target. Median implies +1291%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Nov 14, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Jul 8, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Nov 13, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
May 24, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
Feb 3, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
Jul 18, 2022Dawson James
DOWNGRADE
DOWNGRADENeutral

Insider ledger

Form 4
$0
bought · 0 insiders
$125.0K
sold · 1 insider
DateInsiderTypeValue
Jul 24, 2026
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$3.2K
Jul 23, 2026
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$71.3K
Jul 22, 2026
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$50.5K
Dec 23, 2025
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
OTHER238,095 sh
Jan 7, 2025
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$30.2K
Jan 6, 2025
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$38.5K
Dec 30, 2024
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$79.1K
Dec 24, 2024
Francisco Trust under agreement dated February 28, 1996
10%+ Owner
SELL$9.2K

Earnings setup

Estimates
Nov 11
reports in 15 days
−$0.04
EPS estimate, this quarter
0%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.04-$0.06–-$0.03-33.3%$1.4M
Next Q$0.02-$0.02–$0.05-12.5%$3.0M
Current FY-$0.14-$0.15–-$0.13-44.8%$6.6M
Next FY$0.02-$0.08–$0.14-30.0%$12.8M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Empery Asset Management, LP disclosed a new 8.35% passive stake in Dyadic International Inc. via a Schedule 13G filed…
SC 13G — Impact 4/10
Oct 2, 2026 Listing status
Listing Status: DYAI — Deficient (was Normal)
Dyadic International, Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Sep 25, 2026 SEC
Dyadic International received two Nasdaq deficiency notices on September 25, 2026: one for failing to maintain the…
8-K — Impact 7/10
Sep 21, 2026 SEC
Dyadic International's S-1 registration statement (File No. 333-298902) became effective on September 18, 2026, under…
EFFECT — Impact 5/10
Jul 24, 2026 Insider
Francisco Trust under agreement dated February 28, 1996 sold 2,616 shares
10%+ Owner @ $1.21 ($3.2K)
Jul 23, 2026 Insider
Francisco Trust under agreement dated February 28, 1996 sold 54,760 shares
10%+ Owner @ $1.30 ($71.3K)
Jul 22, 2026 Insider
Francisco Trust under agreement dated February 28, 1996 sold 38,016 shares
10%+ Owner @ $1.33 ($50.5K)
Jun 30, 2026 Inst.
BlackRock, Inc. — TRIM
197,749 shares ($177.2K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
DYAI Q3 2026 Earnings Scheduled — 2026-11-11
Recent
Oct 2, 2026
Listing
Listing Status: DYAI — Deficient (was Normal)
Dyadic International, Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Aug 12, 2026
Earnings
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Aug 12, 2026
Earnings date
DYAI Q2 2026 Earnings Scheduled — 2026-08-12
Jul 23, 2026
Listing
Listing Status: DYAI — Normal (was Deficient)
Dyadic International, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jul 16, 2026
Press release
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

SecBot reports

9 filings · 3 press releases · 0 bullish · 6 bearish · 3 neutral
All DYAI filing & press-release reports (12)